GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dingdang Health Technology Group Ltd (HKSE:09886) » Definitions » Debt-to-EBITDA

Dingdang Health Technology Group (HKSE:09886) Debt-to-EBITDA : -0.68 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Dingdang Health Technology Group Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Dingdang Health Technology Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$61 Mil. Dingdang Health Technology Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$92 Mil. Dingdang Health Technology Group's annualized EBITDA for the quarter that ended in Dec. 2023 was HK$-227 Mil. Dingdang Health Technology Group's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.68.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Dingdang Health Technology Group's Debt-to-EBITDA or its related term are showing as below:

HKSE:09886' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.91   Med: -0.38   Max: -0.06
Current: -0.66

During the past 6 years, the highest Debt-to-EBITDA Ratio of Dingdang Health Technology Group was -0.06. The lowest was -1.91. And the median was -0.38.

HKSE:09886's Debt-to-EBITDA is ranked worse than
100% of 429 companies
in the Healthcare Providers & Services industry
Industry Median: 2.57 vs HKSE:09886: -0.66

Dingdang Health Technology Group Debt-to-EBITDA Historical Data

The historical data trend for Dingdang Health Technology Group's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dingdang Health Technology Group Debt-to-EBITDA Chart

Dingdang Health Technology Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial -0.59 -0.17 -0.11 -0.06 -1.91

Dingdang Health Technology Group Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only -0.19 -0.13 -0.04 -0.67 -0.68

Competitive Comparison of Dingdang Health Technology Group's Debt-to-EBITDA

For the Health Information Services subindustry, Dingdang Health Technology Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dingdang Health Technology Group's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dingdang Health Technology Group's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Dingdang Health Technology Group's Debt-to-EBITDA falls into.



Dingdang Health Technology Group Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Dingdang Health Technology Group's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(61.343 + 92.015) / -80.229
=-1.91

Dingdang Health Technology Group's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(61.343 + 92.015) / -226.728
=-0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.


Dingdang Health Technology Group  (HKSE:09886) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Dingdang Health Technology Group Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Dingdang Health Technology Group's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Dingdang Health Technology Group (HKSE:09886) Business Description

Traded in Other Exchanges
N/A
Address
Dengshikou Street, Building 1, Yard 50, Dongcheng District, Beijing, CHN
Dingdang Health Technology Group Ltd is an investment holding company and its subsidiaries are principally engaged in the provision of pharmaceutical and healthcare business in the PRC. It is transforming and reshaping China's healthcare industry by pioneering on-demand pharmaceutical retail and medical consultation, with online-to-offline solutions.
Executives
Yang Yibin 2201 Interest of corporation controlled by you
Tpg Operating Group Iii, L.p. 2201 Interest of corporation controlled by you
Tpg Inc. 2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong Kong Gu Shen Zhen You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Zi Ben Guan Li Shen Zhen You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong Kong Gu You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Yin Jin Rong Kong Gu Shen Zhen You Xian Gong Si 2201 Interest of corporation controlled by you
Xing Xin You Xian Gong Si
Jian Xing You Xian Gong Si
Zhi Ying Ji Tuan You Xian Gong Si
Jian Fa You Xian Gong Si
Jin Fa You Xian Gong Si
Zhi Sheng Qi Ye You Xian Gong Si
Chuang Ji Tou Zi You Xian Gong Si

Dingdang Health Technology Group (HKSE:09886) Headlines

No Headlines